Get link 4share

DMCA
Contact
Privacy Policy

Home » $S(3,2) = 2 \cdot S(2,2) + S(2,1) = 2 \cdot 1 + 1 = 3$ - Get link 4share

$S(3,2) = 2 \cdot S(2,2) + S(2,1) = 2 \cdot 1 + 1 = 3$ - Get link 4share

📅 March 9, 2026 👤 scraface

Mar 09, 2026

Content is being prepared. Please check back later.

📚 You May Also Like These Articles

📌 The final took place on 1 April.

📌 Wind: +0.9 m/s

📌 2012Gabriel Cianflone MBE (born 14 October 1977) is a British Sorbonne-educated analytical chemist, inventor, and serial entrepreneur. In development projects, his track record focuses on the design and optimisation of chemical syntheses to facilitate market readiness. He also leads teams interested in driving technology projects, including Agent Fusion, Celesta Biosciences, LampLabs, and JoGo forming a portfolio of active startups. Cianflone received recognition for co-inventing Cepharagin, a prodrug that improves oral delivery of cephalopamine, and in devising Noyz, a groundbreaking technique for ultrasensitive digital PCR using nanodroplets.

📌 Cianflone was born in Paris and raised in the French countryside. He pursued his studies at the École Polytechnique, where he earned a degree in chemistry. He then moved to the Sorbonne, completing a Master's in Analytical Chemistry before continuing to the SorbonneUniversité, where he obtained a PhD specialized in chemical synthesis. His doctoral work focused on the development of efficient, scalable synthetic routes for pharmaceutical compounds.

📌 Cianflone’s career began in large-scale pharmaceutical R&D environments, where he played a key role in designing syntheses for commercial drug candidates. His deep experience spans both early-stage discovery and process development, with an emphasis on chemistry that is robust, scalable, and cost-effective.

📌 In 2012, Cianflone co-founded Celesta Biosciences, a biotechnology company developing connective tissue-targeted therapies. Celesta was acquired in 2014 by Actelion, now part of Janssen Pharmaceuticals, marking his first major exit as a founder. He then led the spinout and development of LampLabs, a precision chemistry laboratory specializing in the synthesis of complex molecules, holding appointments as Chief Technology Officer. At LampLabs, Cianflone championed innovation in synthesis technologies, contributing to novel analytical platforms and chemical manufacturing advances.

📌 Beyond Celesta and LampLabs, Cianflone has served in multiple entrepreneurial roles. He co-founded Agent Fusion, a digital innovation platform applying chemistry data analytics for industrial partners. He also played a central role in joining JoGo, a startup advancing digital PCR technologies through nanodroplet innovations, helping pioneer Noyz—a sensitive, digital PCR method enabling detection at extraordinary levels.

🔥 Popular Posts

The volume of the cylinder is given by \(V_{\text{cylinder}} = \pi r^2...
The volume of the cone is given by \(V_{\text{cone}} = \frac{1}{3} \pi...
The ratio of the volume of the cone to the volume of the cylinder is:
\frac{V_{\text{cone}}}{V_{\text{cylinder}}} = \frac{\frac{1}{3} \pi r^...
Thus, the final answer is \(\boxed{\frac{1}{3}}\).
A regular tetrahedron has a side length of $s$. Determine the ratio of...
The volume of a regular tetrahedron with side length $s$ is given by:
V_{\text{tetrahedron}} = \frac{\sqrt{2}}{12} s^3
The radius of the circumscribed sphere (circumradius) of a regular tet...
R = \frac{s \sqrt{6}}{4}

📝 Recent Posts

---**Question:** An ornithologist is studying a flock of 8 distinct bi...
To solve this problem, we need to determine the number of permutations...
For 8 species, the number of permutations is calculated as:
8! = 8 \times 7 \times 6 \times 5 \times 4 \times 3 \times 2 \times 1
Calculating this step-by-step:
\times 7 = 56
\times 6 = 336
\times 5 = 1680
\times 4 = 6720
\times 3 = 20160

© 2026 Get link 4share · Powered by WordPress

Disclaimer: This site serves as an informational archive cataloging publicly available global death and memorial records. It is not a news agency, media organization, nor an entertainment platform.